Excelimmune's Unattributed VC Round

Excelimmune raised a round of funding on July 20, 2010.

Excelimmune is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. This next generation technolog…

Articles about Excelimmune's Unattributed VC Round: